Published in Psychiatry Investig on August 26, 2011
Times to Discontinue Antidepressants Over 6 Months in Patients with Major Depressive Disorder. Psychiatry Investig (2016) 0.75
Clinical Validation of the Psychotic Depression Assessment Scale, Hamilton Depression Rating Scale-6, and Brief Psychiatric Rating Scale-5: Results from the Clinical Research Center for Depression Study. Psychiatry Investig (2017) 0.75
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry (1994) 48.75
The assessment of anxiety states by rating. Br J Med Psychol (1959) 24.58
Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. Am J Psychiatry (2000) 5.38
Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study. Am J Psychiatry (2009) 5.05
Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry (2006) 2.86
The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared. J Affect Disord (2000) 2.68
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care. World J Biol Psychiatry (2007) 2.40
Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord (2000) 2.26
Accelerating response to antidepressant treatment in depression: a review and clinical suggestions. Prog Neuropsychopharmacol Biol Psychiatry (2009) 2.25
Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders. Biol Psychiatry (2007) 2.11
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol (2008) 2.11
A survey of combination antidepressant use in Australia. Australas Psychiatry (2007) 1.98
Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents. Biol Psychiatry (2007) 1.68
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder. World J Biol Psychiatry (2002) 1.63
Social functioning in depression: a review. J Clin Psychiatry (2000) 1.62
Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy. J Clin Psychiatry (1997) 1.61
Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices. Arch Gen Psychiatry (1999) 1.52
Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study. Eur Psychiatry (2008) 1.49
5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. J Neurochem (2001) 1.43
Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. J Clin Psychiatry (2009) 1.42
Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression. Neuropsychopharmacology (2004) 1.38
Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases. Br J Clin Pharmacol (2007) 1.27
The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis. Eur Arch Psychiatry Clin Neurosci (2009) 1.23
Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release. Prog Neuropsychopharmacol Biol Psychiatry (2008) 1.21
Atypical antipsychotics in bipolar depression: potential mechanisms of action. J Clin Psychiatry (2005) 1.17
Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression. Int Clin Psychopharmacol (2010) 1.08
Use of bupropion in combination with serotonin reuptake inhibitors. Biol Psychiatry (2005) 1.05
Acceptability of second-step treatments to depressed outpatients: a STAR*D report. Am J Psychiatry (2007) 0.93
Venlafaxine: a 2003 update. Clin Ther (2003) 0.90
Limitations in efficacy of antidepressant monotherapy. J Clin Psychiatry (2007) 0.89
A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression. J Clin Psychiatry (1998) 0.88
Relationship between a history of a suicide attempt and treatment outcomes in patients with depression. J Clin Psychopharmacol (2011) 0.87
Quetiapine XR: current status for the treatment of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.87
Utility of atypical antipsychotics in the treatment of resistant unipolar depression. CNS Drugs (2009) 0.86
Augmentation strategies for treatment-resistant depression. Curr Opin Psychiatry (2009) 0.85
Biochemical hypotheses on antidepressant drugs: a guide for clinicians or a toy for pharmacologists? Psychol Med (1988) 0.84
Predictors of 12-week remission in a nationwide cohort of people with depressive disorders: the CRESCEND study. Hum Psychopharmacol (2011) 0.83
Antidepressant and benzodiazepine for major depression. Cochrane Database Syst Rev (2002) 0.83
Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression. Biol Psychiatry (2002) 0.83
Combining antidepressant therapies from the initiation of treatment: a paradigm shift for major depression. J Clin Psychiatry (2009) 0.81
[Antidepressive efficacy of quetiapine XR in unipolar major depression--the role of early onset of action and sleep-improving effect in decreasing suicide risk]. Neuropsychopharmacol Hung (2009) 0.77
Use of antidepressant combinations: which, when and why? Results of a Spanish survey. Acta Psychiatr Scand Suppl (2005) 0.76
Is shoulder pain for three months or longer correlated with depression, anxiety, and sleep disturbance? J Shoulder Elbow Surg (2012) 2.14
Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders. Biol Psychiatry (2007) 2.11
Short-term testosterone augmentation in male schizophrenics: a randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol (2008) 2.09
Inhibition of corneal neovascularization by subconjunctival and topical bevacizumab and sunitinib in a rabbit model. Cornea (2013) 2.00
Predictive value of folate, vitamin B12 and homocysteine levels in late-life depression. Br J Psychiatry (2008) 1.88
Role of angiogenic growth factors and inflammatory cytokine on recurrence of chronic subdural hematoma. Surg Neurol (2008) 1.74
Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder. Depress Anxiety (2005) 1.64
Merlin, a tumor suppressor, interacts with transactivation-responsive RNA-binding protein and inhibits its oncogenic activity. J Biol Chem (2004) 1.53
Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.48
Quinone oxidoreductase (NQO1) gene polymorphism (609C/T) may be associated with tardive dyskinesia, but not with the development of schizophrenia. Int J Neuropsychopharmacol (2004) 1.43
Effectiveness of papaverine cisternal irrigation for cerebral vasospasm after aneurysmal subarachnoid hemorrhage and measurement of biomarkers. Neurol Sci (2013) 1.40
Vascular risk factors and incident late-life depression in a Korean population. Br J Psychiatry (2006) 1.37
Physical health, depression and cognitive function as correlates of disability in an older Korean population. Int J Geriatr Psychiatry (2005) 1.31
Dental health, nutritional status and recent-onset dementia in a Korean community population. Int J Geriatr Psychiatry (2007) 1.27
Insomnia, depression, and physical disorders in late life: a 2-year longitudinal community study in Koreans. Sleep (2009) 1.24
Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. Ann N Y Acad Sci (2004) 1.23
Suicide, an urgent health issue in Korea. J Korean Med Sci (2013) 1.22
Bullying and victimization behaviors in boys and girls at South Korean primary schools. J Am Acad Child Adolesc Psychiatry (2006) 1.22
Does therapeutic hypothermia benefit adult cardiac arrest patients presenting with non-shockable initial rhythms?: A systematic review and meta-analysis of randomized and non-randomized studies. Resuscitation (2011) 1.19
Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder. Brain Res (2006) 1.18
Spectrum of mutations in Noonan syndrome and their correlation with phenotypes. J Pediatr (2011) 1.17
Peri-MAC depression of a nociceptive withdrawal reflex is accompanied by reduced dorsal horn activity with halothane but not isoflurane. Anesthesiology (2003) 1.16
Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone. J Clin Psychiatry (2002) 1.14
Prevalence and correlates of late-life depression compared between urban and rural populations in Korea. Int J Geriatr Psychiatry (2002) 1.10
International study on antidepressant prescription pattern at 20 teaching hospitals and major psychiatric institutions in East Asia: Analysis of 1898 cases from China, Japan, Korea, Singapore and Taiwan. Psychiatry Clin Neurosci (2007) 1.09
Name change for schizophrenia. Schizophr Bull (2014) 1.08
Insulin resistance and inflammation may have an additional role in the link between cystatin C and cardiovascular disease in type 2 diabetes mellitus patients. Metabolism (2009) 1.07
Usability of ringed polytetrafluoroethylene grafts for middle hepatic vein reconstruction during living donor liver transplantation. Liver Transpl (2012) 1.07
Clinical analysis of hemodialysis vascular access: comparision of autogenous arterioveonus fistula & arteriovenous prosthetic graft. Korean J Thorac Cardiovasc Surg (2011) 1.06
Tracheal intubation using Macintosh and 2 video laryngoscopes with and without chest compressions. Am J Emerg Med (2010) 1.06
Leg length, cognitive impairment and cognitive decline in an African-Caribbean population. Int J Geriatr Psychiatry (2006) 1.06
Risperidone versus olanzapine for the treatment of delirium. Hum Psychopharmacol (2010) 1.05
Diagnostic validity of assessment scales for depression in patients with schizophrenia. Psychiatry Res (2006) 1.02
Management of schizophrenia with obsessive-compulsive features. Psychiatr Clin North Am (2009) 1.00
Chronic mild stress decreases survival, but not proliferation, of new-born cells in adult rat hippocampus. Exp Mol Med (2006) 0.99
Identifying metabolically obese but normal-weight (MONW) individuals in a nondiabetic Korean population: the Chungju Metabolic disease Cohort (CMC) study. Clin Endocrinol (Oxf) (2011) 0.99
Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury. Hum Psychopharmacol (2005) 0.98
BDNF genotype potentially modifying the association between incident stroke and depression. Neurobiol Aging (2007) 0.98
BanI polymorphism of the cytosolic phospholipase A2 gene and mood disorders in the Korean population. Neuropsychobiology (2004) 0.98
Associations between head circumference, leg length and dementia in a Korean population. Int J Geriatr Psychiatry (2008) 0.98
Vascular disease/risk and late-life depression in a Korean community population. Br J Psychiatry (2004) 0.97
Does arm length indicate cognitive and functional reserve? Int J Geriatr Psychiatry (2005) 0.95
Aripiprazole augmentation for treatment of patients with inadequate antidepressants response. Depress Anxiety (2007) 0.95
Association of SLC6A4 methylation with early adversity, characteristics and outcomes in depression. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.95
Family history influences the early onset of hepatocellular carcinoma. World J Gastroenterol (2012) 0.95
Assessment of cerebrocortical areas associated with sexual arousal in depressive women using functional MR imaging. J Sex Med (2008) 0.94
The clinical research center for depression study: baseline characteristics of a korean long-term hospital-based observational collaborative prospective cohort study. Psychiatry Investig (2010) 0.94
PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype-phenotype correlation in Korean patients with Noonan syndrome. J Hum Genet (2008) 0.94
Arabidopsis MKK4 mediates osmotic-stress response via its regulation of MPK3 activity. Biochem Biophys Res Commun (2011) 0.93
Smoking rate trends in Korean occupational groups: analysis of KNHANES 1998-2009 data. J Occup Health (2012) 0.93
Reconstruction of inferior right hepatic veins in living donor liver transplantation using right liver grafts. Liver Transpl (2012) 0.93
Distinctive clinical characteristics and suicidal tendencies of patients with anxious depression. J Nerv Ment Dis (2011) 0.93
Lifetime urban/rural residence, social support and late-life depression in Korea. Int J Geriatr Psychiatry (2004) 0.93
Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia. Psychoneuroendocrinology (2007) 0.92
Direct versus video laryngoscopic intubation by novice prehospital intubators with and without chest compressions: A pilot manikin study. Prehosp Emerg Care (2010) 0.92
Subjective memory impairment, cognitive function and depression--a community study in older Koreans. Dement Geriatr Cogn Disord (2003) 0.92
Serotonergic and BDNF genes and risk of depression after stroke. J Affect Disord (2011) 0.91